CF-BI
|
C406222-25mg
|
≥98%(HPLC) |
N/A |
25mg
|
¥ 3080.9
|
期货,请咨询 |
阿拉丁 |
8-氯-1-(3-氯丙基)可可碱
|
C406221-5g
|
≥95%(HPLC) |
N/A |
5g
|
¥ 1288.9
|
期货,请咨询 |
阿拉丁 |
8-氯-1-(3-氯丙基)可可碱
|
C406221-25g
|
≥95%(HPLC) |
N/A |
25g
|
¥ 4110.9
|
期货,请咨询 |
阿拉丁 |
1-氯-3-十二烷基苯
|
C406220-1g
|
≥96% |
2732821-93-9 |
1g
|
¥ 449.9
|
期货,请咨询 |
阿拉丁 |
环己甲胺氢溴酸盐
|
C406217-5g
|
≥98% |
3218-02-8 |
5g
|
¥ 1129.9
|
现货 |
阿拉丁 |
环己甲胺氢溴酸盐
|
C406217-1g
|
≥98% |
3218-02-8 |
1g
|
¥ 329.9
|
现货 |
阿拉丁 |
考马斯亮蓝G-250 (即用型溶液) [电泳用]
|
C406216-500ml
|
|
N/A |
500ml
|
¥ 994.9
|
期货,请咨询 |
阿拉丁 |
4-氯-1-萘酚 (即用型溶液) [用于蛋白免疫印迹法]
|
C406215-100ml
|
|
N/A |
100ml
|
¥ 711.9
|
期货,请咨询 |
阿拉丁 |
壳寡糖
|
C406214-25g
|
分子量≤1000 |
148411-57-8 |
25g
|
¥ 349.9
|
现货 |
阿拉丁 |
壳寡糖
|
C406214-100g
|
分子量≤1000 |
148411-57-8 |
100g
|
¥ 899.9
|
现货 |
阿拉丁 |
几丁质寡糖 (含N-乙酰基葡萄糖胺)
|
C406213-25g
|
|
N/A |
25g
|
¥ 999.9
|
现货 |
阿拉丁 |
[[1,3-双(2,6-二异丙苯基)咪唑-2-亚基](4'-甲氧基乙酰苯胺)氯化钯(II)]
|
C406212-200mg
|
≥98%(T) |
N/A |
200mg
|
¥ 340.9
|
期货,请咨询 |
阿拉丁 |
[[1,3-双(2,6-二异丙苯基)咪唑-2-亚基](4'-甲氧基乙酰苯胺)氯化钯(II)]
|
C406212-1g
|
≥98%(T) |
N/A |
1g
|
¥ 1545.9
|
期货,请咨询 |
阿拉丁 |
氯邻二甲苯 (3-和4-异构体混合物)
|
C406210-500g
|
≥97%(GC) |
N/A |
500g
|
¥ 505.9
|
期货,请咨询 |
阿拉丁 |
氯邻二甲苯 (3-和4-异构体混合物)
|
C406210-25g
|
≥97%(GC) |
N/A |
25g
|
¥ 176.9
|
期货,请咨询 |
阿拉丁 |
纤维素TEAE 容量:0.72 meq/g
|
C406206-10g
|
|
N/A |
10g
|
¥ 309.9
|
期货,请咨询 |
阿拉丁 |
DL-酒石酸钙 四水合物
|
C406137-25g
|
≥98%(T) |
N/A |
25g
|
¥ 2024.9
|
期货,请咨询 |
阿拉丁 |
3-氯-4-甲氧基苄胺
|
C405721-5g
|
≥98% |
115514-77-7 |
5g
|
¥ 67.9
|
现货 |
阿拉丁 |
3-氯-4-甲氧基苄胺
|
C405721-1g
|
≥98% |
115514-77-7 |
1g
|
¥ 26.9
|
现货 |
阿拉丁 |
双(三氟甲磺酰基)亚胺铈(III)
|
C405720-1g
|
≥98%(T) |
1046099-39-1 |
1g
|
¥ 577.9
|
期货,请咨询 |
阿拉丁 |
双(九氟丁基磺酰基)亚胺钙(II)
|
C405718-1g
|
≥95% |
689282-13-1 |
1g
|
¥ 249.9
|
现货 |
阿拉丁 |
(环己基-CAAC)Rh(COD)Cl
|
C405717-100mg
|
≥98%(NMR) |
1801869-83-9 |
100mg
|
¥ 989.9
|
期货,请咨询 |
阿拉丁 |
顺-1-苄基-2,6-二氰基哌啶
|
C405696-1g
|
≥95%(N) |
106006-86-4 |
1g
|
¥ 1432.9
|
期货,请咨询 |
阿拉丁 |
3-甲基-2-氧代丁酸钙
|
C405686-5g
|
≥97% |
51828-94-5 |
5g
|
¥ 555.9
|
现货 |
阿拉丁 |